Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical and Experimental Metastasis

• Publication date

  2010-03-26

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10585-010-9316-1PMID 20339907PMCID PMC3053599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.

  2009cited by this paper
• alpha(5)beta(1) Integrin Ligand PHSRN Induces Invasion and alpha(5) mRNA in Endothelial Cells to Stimulate Angiogenesis.

  2009cited by this paper
• Affinity enhancement of complementary peptide recognition.

  2009cited by this paper
• α5β1 Integrin Ligand PHSRN Induces Invasion and α5 mRNA in Endothelial Cells to Stimulate Angiogenesis

  2009cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis.

  2008cited by this paper
• Stepping out of the flow: capillary extravasation in cancer metastasis

  2007influential reference
• Prostate cancer : biology, genetics, and the new therapeutics

  2007cited by this paper
• ID genes mediate tumor reinitiation during breast cancer lung metastasis

  2007cited by this paper
• Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.

  2006cited by this paper
• Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours

  2006cited by this paper
• Neuroanatomical tract-tracing 3 : molecules, neurons, and systems

  2006cited by this paper
• A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo

  2006cited by this paper
• RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility

  2006cited by this paper
• Tract-Tracing in Developing Systems and in Postmortem Human Material Using Carbocyanine Dyes

  2006cited by this paper
• In vivo and in vitro antitumor activity of butyroyloxymethyl‐diethyl phosphate (AN‐7), a histone deacetylase inhibitor, in human prostate cancer

  2005cited by this paper
• Targeting invasion induction as a therapeutic strategy for the treatment of cancer.

  2005cited by this paper
• Pleural effusion as presentation of metastatic adenocarcinoma of prostate.

  2005cited by this paper
• Integrins and Prostate Cancer Metastases

  2004cited by this paper
• Integrin Fibronectin Receptors in Matrix Metalloproteinase-1–Dependent Invasion by Breast Cancer and Mammary Epithelial Cells

  2004influential reference
• Dynamic process of prostate cancer metastasis to bone

  2004cited by this paper
• Prostate Cancer Diagnosis, Staging and Survival

  2004cited by this paper
• The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2-mediated transformation.

  2003cited by this paper
• Case of the season. Inflammatory breast cancer.

  2003cited by this paper
• Interactions of surfactant protein D with fatty acids.

  2003cited by this paper
• p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion.

  2003cited by this paper
• Inhibition of integrin α5β1 function with a small peptide (ATN‐161) plus continuous 5‐FU infusion reduces colorectal liver metastases and improves survival in mice

  2003cited by this paper
• Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.

  2002cited by this paper
• Radiosensitivity with Par-4 Expression in Prostate Cancer

  2002cited by this paper
• Synthetic Peptides: A User's Guide

  2002cited by this paper
• Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

  2002cited by this paper
• Evaluation of the Synthetic Product

  2002cited by this paper
• Lethal Metastatic Human Prostate Cancer

  2001cited by this paper
• CHEMICAL SYNTHESIS OF PEPTIDES

  2000cited by this paper
• Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V3 loop.

  2000cited by this paper
• Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo

  2000cited by this paper
• Lethal Metastatic Human Prostate Cancer: Autopsy Studies and Characteristics of Metastases

  2000cited by this paper
• the PHSCN Sequence in Prostate Carcinoma Anti-invasive , Antitumorigenic , and Antimetastatic Activities of Updated Version

  2000influential reference
• Interactions between cancer cells and the endothelium in metastasis

  2000cited by this paper
• Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

  2000cited by this paper
• ERBB-2 overexpression confers PI 3 ′ kinase-dependent invasion capacity on human mammary epithelial cells

  2000cited by this paper
• The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice.

  2000influential reference
• The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.

  2000cited by this paper
• Peptide and Protein Drug Analysis

  1999cited by this paper
• RGD‐recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro

  1999cited by this paper
• TALL-104 cell therapy of human solid tumors implanted in immunodeficient (SCID) mice.

  1998cited by this paper
• Defining the Topology of Integrin α5β1-Fibronectin Interactions Using Inhibitory Anti-α5 and Anti-β1 Monoclonal Antibodies

  1997cited by this paper
• Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit.

  1997cited by this paper
• Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix.

  1997cited by this paper
• Induction of experimental bone metastasis in mice by transfection of integrin α4β1 into tumor cells

  1996cited by this paper
• Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells.

  1996cited by this paper
• Expression of cellular adhesion molecules on human prostate tumor cell lines

  1995cited by this paper
• Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin

  1995cited by this paper
• Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line

  1995cited by this paper
• Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin.

  1994cited by this paper
• Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development.

  1994cited by this paper
• Structural and functional properties of region II-plus of the malaria circumsporozoite protein

  1994cited by this paper
• Vital dye labelling of Xenopus laevis trunk neural crest reveals multipotency and novel pathways of migration.

  1993cited by this paper
• Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis.

  1993cited by this paper
• The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.

  1992cited by this paper
• Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis.

  1991cited by this paper
• A study in developing visual systems with a new method of staining neurones and their processes in fixed tissue.

  1987cited by this paper
• The course of metastatic disease originating from carcinoma of the prostate

  1985cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• Physiology of fibronectin.

  1984cited by this paper
• Fibronectin: purification, immunochemical properties, and biological activities.

  1982cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• Isolation of a human prostate carcinoma cell line (DU 145)

  1978cited by this paper
• Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

  1970cited by this paper
• Metastases from cancer of the prostate. Autopsy and roentgenological findings

  1954cited by this paper

• Biomimetic nanoparticles in cancer photodynamic therapy: a review of targeted delivery systems and therapeutic outcomes

  2026cites this paper
• L‐lysine Janus Dendrimer Conjugate with Naproxen and Mefenamic Acid and its Anticancer Activity

  2024cites this paper
• Targeting integrin α5β1 in urological tumors: opportunities and challenges

  2023cites this paper
• Dendrimer-Based Nanoparticulate Delivery System for Cancer Therapy

  2019cites this paper
• COMPUTATIONAL TECHNIQUES TO EVALUATE AT ATOMIC LEVEL THE MECHANISM OF MOLECULAR BINDING

  2017cites this paper
• Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals

  2017cites this paper
• Bone Metastasis from Renal Cell Carcinoma

  2016cites this paper
• Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin

  2016cites this paper
• Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes

  2016cites this paper
• Targeting Alpha5 Beta1 Integrin to Prevent Metastatic Breast Cancer Cell Invasion: PhScN Target Site Definition and Plasma Stability

  2015cites this paper
• PAMAM dendrimers: destined for success or doomed to fail? Plain and modified PAMAM dendrimers in the context of biomedical applications.

  2015cites this paper
• Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling.

  2015cites this paper
• &agr;5&bgr;1 Integrin Signaling Mediates Oxidized Low-Density Lipoprotein–Induced Inflammation and Early Atherosclerosis

  2014cites this paper
• A d-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization

  2014influential citation
• Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors

  2013cites this paper
• Award Number: TITLE: “Targeting Alpha5 Beta1 Integrin to Prevent Metastatic Breast Cancer Cell Invasion: PhScN Target Site Definition and Plasma Stability” PRINCIPAL INVESTIGATOR:

  2013cites this paper
• Copper(II) coordination properties of the integrin ligand sequence PHSRN and its new β-cyclodextrin conjugates.

  2012cites this paper
• RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis

  2012cites this paper
• The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo.

  2011cites this paper
• Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.

  2011cites this paper
• Invasion by Human Pancreatic Cancer Cells 1

  2011cites this paper
• Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells.

  2011cites this paper
• Dendritic Polymers in Oncology: Facts, Features, and Applications

  2011cites this paper